The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...